TRUST CO OF VERMONT - Zander Therapeutics Inc ownership

Back to all holdings Add to watchlist

Zander Therapeutics Inc's ticker is and the CUSIP is 98900P109. A total of 1 filers reported holding Zander Therapeutics Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of Zander Therapeutics Inc
ValueSharesWeighting
Q3 2023$0–2,9410.0%0.00%–
Q2 2023$0–2,9410.0%0.00%–
Q1 2023$0–2,9410.0%0.00%–
Q4 2022$0–2,9410.0%0.00%–
Q3 2022$0–2,941–0.00%–
 Download
Other shareholders
Zander Therapeutics Inc shareholders Q3 2023
NameSharesValueWeighting ↓
TRUST CO OF VERMONT 2,941$00.00%
View complete list of Zander Therapeutics Inc shareholders